A total of 37 potential targets were predicted by network pharmacology, among which TNF, IL-1B, IL-6, ESR1, PPARG, NFκB1, STAT3, and TLR4 may be the key targets of GA in the treatment of acne. The gene discussed is ESR1; the disease is acne.